Literature DB >> 19657089

The role of IL-23/IL-17 axis in lupus nephritis.

Zheng Zhang1, Vasileios C Kyttaris, George C Tsokos.   

Abstract

T cells that express IL-17 infiltrate the kidneys of patients with systemic lupus erythematosus. A significant proportion of these cells are CD3(+)CD4(-)CD8(-) double-negative T cells. In this study, we show that double-negative T cells from MRL/lpr mice express high amounts of IL-17 and that as disease progressively worsens, the expression of IL-17 and of IL-23 receptor in lymphocytes from these mice increases. Lymph node cells from lupus-prone mice, but not control mice, treated in vitro with IL-23 induce nephritis when transferred to non-autoimmune, lymphocyte-deficient Rag-1(-/-) mice. Kidney specimens from these recipient mice show significant Ig and complement deposition. The data indicate that an aberrantly active IL-23/IL-17 axis contributes to the development of nephritis in lupus-prone mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19657089      PMCID: PMC2766304          DOI: 10.4049/jimmunol.0900385

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection.

Authors:  Michelle N Kelly; Jay K Kolls; Kyle Happel; Joseph D Schwartzman; Paul Schwarzenberger; Crescent Combe; Magali Moretto; Imtiaz A Khan
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 2.  IL-17 and Th17 Cells.

Authors:  Thomas Korn; Estelle Bettelli; Mohamed Oukka; Vijay K Kuchroo
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

Review 3.  Clinical presentation and monitoring of lupus nephritis.

Authors:  J E Balow
Journal:  Lupus       Date:  2005       Impact factor: 2.911

4.  Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus.

Authors:  C K Wong; C Y Ho; E K Li; C W Lam
Journal:  Lupus       Date:  2000       Impact factor: 2.911

5.  Pathogenic anti-DNA autoantibody-inducing T helper cell lines from patients with active lupus nephritis: isolation of CD4-8- T helper cell lines that express the gamma delta T-cell antigen receptor.

Authors:  S Rajagopalan; T Zordan; G C Tsokos; S K Datta
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

6.  Activated T lymphocytes in the peripheral blood of patients with systemic lupus erythematosus induce B cells to produce immunoglobulin.

Authors:  G Inghirami; J Simon; J E Balow; G C Tsokos
Journal:  Clin Exp Rheumatol       Date:  1988 Jul-Sep       Impact factor: 4.473

7.  Phenotypic and functional analyses on T-cell subsets in lymph nodes of MRL/Mp-lpr/lpr mice.

Authors:  S Igarashi; M Takiguchi; A Kariyone; K Kano
Journal:  Int Arch Allergy Appl Immunol       Date:  1988

8.  Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice.

Authors:  Susumu Nakae; Aya Nambu; Katsuko Sudo; Yoichiro Iwakura
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

Review 9.  Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease.

Authors:  P L Cohen; R A Eisenberg
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

10.  T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis.

Authors:  S Shivakumar; G C Tsokos; S K Datta
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

View more
  116 in total

Review 1.  T cells as therapeutic targets in SLE.

Authors:  José C Crispín; Vasileios C Kyttaris; Cox Terhorst; George C Tsokos
Journal:  Nat Rev Rheumatol       Date:  2010-05-11       Impact factor: 20.543

Review 2.  Interleukin 17 in vascular inflammation.

Authors:  Sibylle von Vietinghoff; Klaus Ley
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-12       Impact factor: 7.638

Review 3.  Contribution of B-1a cells to systemic lupus erythematosus in the NZM2410 mouse model.

Authors:  Zhiwei Xu; Laurence Morel
Journal:  Ann N Y Acad Sci       Date:  2015-02-26       Impact factor: 5.691

4.  The Th17-defining transcription factor RORγt promotes glomerulonephritis.

Authors:  Oliver M Steinmetz; Shaun A Summers; Poh-Yi Gan; Timothy Semple; Stephen R Holdsworth; A Richard Kitching
Journal:  J Am Soc Nephrol       Date:  2010-12-23       Impact factor: 10.121

Review 5.  Novel Treatments in Lupus.

Authors:  Vasileios C Kyttaris
Journal:  Curr Rheumatol Rep       Date:  2017-03       Impact factor: 4.592

Review 6.  Immune and inflammatory role in renal disease.

Authors:  John D Imig; Michael J Ryan
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

7.  Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane.

Authors:  S A Summers; D Odobasic; M B Khouri; O M Steinmetz; Y Yang; S R Holdsworth; A R Kitching
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

8.  An essential role of interleukin-17 receptor signaling in the development of autoimmune glomerulonephritis.

Authors:  Kritika Ramani; Sudesh Pawaria; Kelly Maers; Anna R Huppler; Sarah L Gaffen; Partha S Biswas
Journal:  J Leukoc Biol       Date:  2014-06-16       Impact factor: 4.962

Review 9.  IL-17 in Renal Immunity and Autoimmunity.

Authors:  Partha S Biswas
Journal:  J Immunol       Date:  2018-12-01       Impact factor: 5.422

10.  Interleukin 23 is elevated in the serum of patients with SLE.

Authors:  Milena Vukelic; Anita Laloo; Vasileios C Kyttaris
Journal:  Lupus       Date:  2020-08-24       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.